Cargando…

Tumour growth rate of carcinoma of the colon and rectum: retrospective cohort study

BACKGROUND: The growth pattern of colorectal cancer is seldom investigated. This cohort study aimed to explore tumour growth rate in colorectal cancers managed non‐surgically or deemed not resectable, and to determine its implication for prognosis. METHODS: Consecutive patients with colonic or recta...

Descripción completa

Detalles Bibliográficos
Autores principales: Burke, J. R., Brown, P., Quyn, A., Lambie, H., Tolan, D., Sagar, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370463/
https://www.ncbi.nlm.nih.gov/pubmed/32996713
http://dx.doi.org/10.1002/bjs5.50355
_version_ 1783739446093414400
author Burke, J. R.
Brown, P.
Quyn, A.
Lambie, H.
Tolan, D.
Sagar, P.
author_facet Burke, J. R.
Brown, P.
Quyn, A.
Lambie, H.
Tolan, D.
Sagar, P.
author_sort Burke, J. R.
collection PubMed
description BACKGROUND: The growth pattern of colorectal cancer is seldom investigated. This cohort study aimed to explore tumour growth rate in colorectal cancers managed non‐surgically or deemed not resectable, and to determine its implication for prognosis. METHODS: Consecutive patients with colonic or rectal adenocarcinoma were identified through the colorectal multidisciplinary team database at Leeds Teaching Hospitals NHS Trust over a 2‐year interval. Patients who received no treatment (surgery, stenting, colonic defunctioning procedures, chemotherapy, radiotherapy) and who underwent CT twice more than 5 weeks apart were included. Multidetector CT/three‐dimensional image analysis was performed independently by three experienced radiologists. RESULTS: Of 804 patients reviewed, 43 colorectal cancers were included in the final analysis. Median age at first CT was 80 (73–85) years and the median interval between scans was 150 (i.q.r. 72–471) days. An increase in T category was demonstrated in 31 of 43 tumours, with a median doubling time of 211 (112–404) days. The median percentage increase in tumour volume was 34·1 (13·3–53·9) per cent per 62 days. The all‐cause 3‐year mortality rate was 81 per cent (35 of 43) with a median survival time of 1·1 (0·4–2·2) years after the initial diagnostic scan. In those obstructed, the relative risk of death from subsequent perforation was 1·26 (95 per cent c.i. 1·07 to 1·49; P = 0·005). CONCLUSION: This study documented a median doubling time of 211 days, with a concerning suggestion of tumour progression, which has implications for the current management standard.
format Online
Article
Text
id pubmed-8370463
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-83704632021-08-18 Tumour growth rate of carcinoma of the colon and rectum: retrospective cohort study Burke, J. R. Brown, P. Quyn, A. Lambie, H. Tolan, D. Sagar, P. BJS Open Original Articles BACKGROUND: The growth pattern of colorectal cancer is seldom investigated. This cohort study aimed to explore tumour growth rate in colorectal cancers managed non‐surgically or deemed not resectable, and to determine its implication for prognosis. METHODS: Consecutive patients with colonic or rectal adenocarcinoma were identified through the colorectal multidisciplinary team database at Leeds Teaching Hospitals NHS Trust over a 2‐year interval. Patients who received no treatment (surgery, stenting, colonic defunctioning procedures, chemotherapy, radiotherapy) and who underwent CT twice more than 5 weeks apart were included. Multidetector CT/three‐dimensional image analysis was performed independently by three experienced radiologists. RESULTS: Of 804 patients reviewed, 43 colorectal cancers were included in the final analysis. Median age at first CT was 80 (73–85) years and the median interval between scans was 150 (i.q.r. 72–471) days. An increase in T category was demonstrated in 31 of 43 tumours, with a median doubling time of 211 (112–404) days. The median percentage increase in tumour volume was 34·1 (13·3–53·9) per cent per 62 days. The all‐cause 3‐year mortality rate was 81 per cent (35 of 43) with a median survival time of 1·1 (0·4–2·2) years after the initial diagnostic scan. In those obstructed, the relative risk of death from subsequent perforation was 1·26 (95 per cent c.i. 1·07 to 1·49; P = 0·005). CONCLUSION: This study documented a median doubling time of 211 days, with a concerning suggestion of tumour progression, which has implications for the current management standard. John Wiley & Sons, Ltd 2020-09-30 /pmc/articles/PMC8370463/ /pubmed/32996713 http://dx.doi.org/10.1002/bjs5.50355 Text en © 2020 The Authors. BJS Open published by John Wiley & Sons Ltd on behalf of British Journal of Surgery Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Burke, J. R.
Brown, P.
Quyn, A.
Lambie, H.
Tolan, D.
Sagar, P.
Tumour growth rate of carcinoma of the colon and rectum: retrospective cohort study
title Tumour growth rate of carcinoma of the colon and rectum: retrospective cohort study
title_full Tumour growth rate of carcinoma of the colon and rectum: retrospective cohort study
title_fullStr Tumour growth rate of carcinoma of the colon and rectum: retrospective cohort study
title_full_unstemmed Tumour growth rate of carcinoma of the colon and rectum: retrospective cohort study
title_short Tumour growth rate of carcinoma of the colon and rectum: retrospective cohort study
title_sort tumour growth rate of carcinoma of the colon and rectum: retrospective cohort study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370463/
https://www.ncbi.nlm.nih.gov/pubmed/32996713
http://dx.doi.org/10.1002/bjs5.50355
work_keys_str_mv AT burkejr tumourgrowthrateofcarcinomaofthecolonandrectumretrospectivecohortstudy
AT brownp tumourgrowthrateofcarcinomaofthecolonandrectumretrospectivecohortstudy
AT quyna tumourgrowthrateofcarcinomaofthecolonandrectumretrospectivecohortstudy
AT lambieh tumourgrowthrateofcarcinomaofthecolonandrectumretrospectivecohortstudy
AT toland tumourgrowthrateofcarcinomaofthecolonandrectumretrospectivecohortstudy
AT sagarp tumourgrowthrateofcarcinomaofthecolonandrectumretrospectivecohortstudy